Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer von VON PAWEL, J, SCHILLER, J. H, CARMICHAEL, J, KREBS, J. B, ROSS, G, LANE, S. R, GRALLA, R, SHEPHERD, F. A, FIELDS, S. Z, KLEISBAUER, J. P, CHRYSSON, N. G, STEWART, D. J, CLARK, P. I, PALMER, M. C, DEPIERRE, A

Volltext

Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study von Jacoulet, P., Depierre, A., Moro, D., Rivière, A., Milleron, B., Quoix, E., Ranfaing, E., Anthoine, D., Lafitte, J. J., Lebeau, B., Kleisbauer, J. P., Massin, F., Fournel, P., Zaegel, M., Leclerc, J. P., Garnier, G., Brambilla, E., Capron, F.

Volltext

Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer von Thomas, P., Robinet, G., Gouva, S., Fournel, P., Léna, H., Le Caer, H., Perol, M., Berard, H., Bombaron, P., Vergnenegre, A., Kleisbauer, J.P.

Volltext

Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study von Thomas, Pascal, Robinet, G., Ferri-Dessens, R.M., Léna, H., Gouva, S., Vernejoux, J.M., Kleisbauer, J.P.

Volltext

Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer von Vergnenègre, A., Daniel, C., Léna, H., Fournel, P., Kleisbauer, J.P., Caer, H. Le, Letreut, J., Paillotin, D., Pérol, M., Bouchaert, E., Preux, P.M., Robinet, G.

Volltext

Usefulness of longitudinal evaluation of Cyfra 21-1 variations in advanced lung cancer monitoring von Hamzaoui, A., Thomas, P., Castelnau, O., Roux, N., Roux, F., Kleisbauer, J.P.

Volltext

Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer von Pérol, M., Guérin, J.C., Thomas, P., Poirier, R., Carles, P., Robinet, G., Kleisbauer, J.P., Paillotin, D., Vergnenègre, A., Balmes, P., Touron, D., Grivaux, M., Pham, E.

Volltext

127 Spirometric control following vinca alkaloids in patients receiving mitomycin von Berard, H., Thomas, P., Castelnau, O., Kleisbauer, J.P.

Volltext

1258 Pronostic value of CYFRA 21.1 variation in lung cancer von Hamzaoui, A., Thomas, P., Castelnau, O., Roux, P., Kleisbauer, J.P.

Volltext

Does G.CSF induce brain metastasis of small cell lung cancer (SCLC)? von Kleisbauer, J.P., Thomas, P., Castelnau, O.

Volltext

Phase II with Taxol ® (Paclitaxel) (T), Carboplatin (C) and brain radiotherapy (RT) in patients (PTS) with inoperable brain metastases (BM) of non-small cell lung cancer (NSCLC) von Robinet, G, Léna, H, Rivière, A, Breton, J.L, Dabouis, G, Kleisbauer, J.P, Thiberville, L, Douillard, J.Y, Pérol, M, Vaylet, F, Dissoubray, C, Grau, B

Volltext

TO09 153SM-EDTMP et contrôle de la douleur liée aux métastases osseuses des cancers bronchiques von Ratsimanohatra, H., Barlesi, F., Robitail, S., Gimenez, C., Astoul, P., Kleisbauer, J.P., Roussel, P.

Volltext

862 Usefulness of longitudinal evaluation of CYFRA 21-1 variations in advanced lung cancer monitoring von Hamzaoui, A., Thomas, P., Castelnau, O., Roux, N., Roux, F., Kleisbauer, J.P.

Volltext

Spreading evaluation in primitive bronchogenic carcinoma: Benefit of cerebral MRI compared to CT scan von Lemiere, C., Peretti-Viton, P., Thomas, P., Gaubert, J.Y., di Stefano-Louineau, D., Kleisbauer, J.P.

Volltext

Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy.: A Phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.) von Thomas, P, Kleisbauer, J.P, Robinet, G, Clavier, J, Poirier, R, Vernenegre, A, Bonnaud, F, Taytard, A, Paillotin, D, Pommier De Santi, P, Barriere, J.R, Pignon, T

Volltext

1109 Detection of human papillomavirus DNA in primary lung carcinoma by nested polymerase chain reaction von Thomas, P., de Lambalerie, X., Garbe, L., Castelnau, O., Kleisbauer, J.P.

Volltext

Preliminary results of a randomised comparative phase III trial of topotecan versus CAV as second-line therapy of small cell lung cancer von Clarke, P., Schiller, J.H., Von Pawel, J., Kleisbauer, J.P., Dobbs, T., Chrysson, N., Dane, G., Hudson, I., DeWitte, M., Fields, S.Z.

Volltext

156 Phase II study of docetaxel (Taxotere ®) in 1st and 2nd line NSCLC von Robinet, G., Kleisbauer, J.P., Thomas, P., Perol, M., Carles, P., Paillotin, D., Lena, H., Poirier, R., Clouet, P., Lenseigne, S., Soares, J.A.

Volltext

254 Carboplatin as radiosensitizer in non-small cell lung cancer after a cisplatin containing chemotherapy. A phase I study of a groupe francais de pneumo-cancerologie (G.F.P.C.) von Thomas, P., Kleisbauer, J.P., Robinet, G., Clavier, J., Poirier, R., Vergnenegre, A., Bonnaud, F., Taytard, A., Paillotin, D., Pommier de Santi, P., Barriere, J.R.

Volltext

Carboplatin as radiosensitizer in non-small cell lung cancer after cisplatin containing chemotherapy von Thomas, P, Kleisbauer, J.P, Robinet, G, Clavier, J, Poirier, R, Vernenegre, A, Bonnaud, F, Taytard, A, Paillotin, D, Pommier De Santi, P, Barriere, J.R, Pignon, T

Volltext